The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Phase 2

Recruiting

• Conditions: COVID
• Interventions: Drug: Ivermectin

• Registration Number: NCT04351347
• Lead Sponsor: Tanta University

Brief Summary

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Detailed Description

Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment

Study Timeline

• Study First Submitted: 2020-04-15
• Study First Submitted QC: 2020-04-15
• Study First Posted: 2020-04-17
• Study Start: 2020-06-16
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-08
• Last Update Posted: 2021-03-10
• Primary Completion: 2030-12-01
• Study Completion: 2030-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients with covid 19

Exclusion Criteria

• Allergy or side effects to treatment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Ivermectin	Ivermectin	Ivermectin alone in larger doses

Primary Outcome Measures

Name	Time	Method
Number of patients with improvement or died	1 month	The number of patients with improvement or death

Trial Locations

Locations (1)

Tanta University; 🇪🇬 Tanta, Egypt